International Stem Cell (ISCO) Total Debt (2011 - 2026)

International Stem Cell (ISCO) has reported Total Debt for 16 consecutive years, with $3.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Debt changed 0.43% year-over-year to $3.3 million in Q2 2026; TTM through Jun 2026 was $3.3 million, a 0.43% change from a year earlier, with the FY2025 full-year figure at $3.3 million, down 1.62% from the prior year.
• Total Debt was $3.3 million for Q2 2026 at International Stem Cell, down from $3.3 million in the prior quarter.
• Over five years, Total Debt peaked at $3.5 million in Q2 2024 and troughed at $3.2 million in Q1 2022.
• A 5-year average of $3.4 million and a median of $3.4 million in 2023 frame the typical range for Total Debt.
• Across the five-year window, Total Debt grew 13.08% in 2022 and retreated 7.18% in 2025, its largest moves.
• Over 5 years, Total Debt stood at $3.3 million in 2022, then gained by 3.97% to $3.5 million in 2023, then declined by 1.79% to $3.4 million in 2024, then declined by 1.62% to $3.3 million in 2025, then retreated by 2.51% to $3.3 million in 2026.
• The last three Total Debt figures came in at $3.3 million (Q2 2026), $3.3 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.